PMID- 38299087 OWN - NLM STAT- MEDLINE DCOM- 20240202 LR - 20240206 IS - 1986-5961 (Electronic) IS - 0350-199X (Print) IS - 0350-199X (Linking) VI - 77 IP - 5 DP - 2023 TI - Indoor Aeroallergen Sensitization and Associated Factors in Hospitalized Children with Asthma Exacerbations. PG - 338-344 LID - 10.5455/medarh.2023.77.338-344 [doi] AB - BACKGROUND: Allergic asthma represents the most popular phenotype of childhood asthma and is characterized by eosinophilic airway inflammation associated with specific immunoglobulin E (IgE) antibodies sensitization to various allergens, as evidenced by serology or skin prick test.(2) Sensitization to indoor aeroallergens is associated with severe asthma and severe asthma exacerbations. OBJECTIVE: This study aimed to identify the prevalence of aeroallergen sensitization and its associated factors in children with an asthma exacerbation in Vietnam. METHODS: A cross-sectional study was conducted at Children's Hospital 1, Ho Chi Minh City (HCMC). Children who were aged 3 to 15 and admitted to the hospital with moderate or severe asthma exacerbation were recruited to the study. Data was collected from interviews and medical records. SPT was used to identify aeroallergen sensitization. The association between school-age, living area, and passive smoking with the odds of aeroallergen sensitization was assessed using a multivariable logistic regression. RESULTS: The prevalence of aeroallergen sensitization was 82.6% and this figure in school-age children was higher than that in preschool-age ones (93.8% vs 72.1%, p=0.001). School-age, living in HCMC, and passive smoking significantly increased the odds of aeroallergen sensitization in asthmatic children with adjusted OR [95%CI] as 6.9 [2.1-23.3], 4.1 [1.5-11.5], and 2.9 [1.0-8.4], respectively. Asthmatic children with aeroallergen sensitization required more hours to resolve an asthma exacerbation than those without (22.4 vs 15.2, p=0.006). CONCLUSION: Aeroallergen sensitization was common in hospitalized children with moderate or severe asthma exacerbation. It is necessary to establish environmental policy and screening practices of aeroallergen sensitization to improve the quality of asthma management for Vietnamese children. CI - (c) 2023 Nguyen Thuy Van Thao, To Gia Kien, Tran Anh Tuan, Nguyen Minh Duc, Phan Minh Hoang, Le Thuong Vu. FAU - Thao, Nguyen Thuy Van AU - Thao NTV AD - Department of Pediatrics, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. AD - Department of General Internal Medicine 2, Children's Hospital 1, Ho Chi Minh City, Vietnam. FAU - Kien, To Gia AU - Kien TG AD - Department of Health Management, Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. FAU - Tuan, Tran Anh AU - Tuan TA AD - Department of Respirology, Children's Hospital 1, Ho Chi Minh City, Vietnam. FAU - Duc, Nguyen Minh AU - Duc NM AD - Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam. FAU - Hoang, Phan Minh AU - Hoang PM AD - Department of Physical therapy and Rehabilitation, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam. AD - Director board, HCMC Hospital for Rehabilitation-Professional diseases. FAU - Vu, Le Thuong AU - Vu LT AD - Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. AD - Department of Respirology, University Medical Center, Ho Chi Minh City, Vietnam. LA - eng PT - Journal Article PL - Bosnia and Herzegovina TA - Med Arch JT - Medical archives (Sarajevo, Bosnia and Herzegovina) JID - 101635337 RN - 0 (Tobacco Smoke Pollution) RN - 0 (Allergens) SB - IM MH - Child MH - Child, Preschool MH - Humans MH - *Tobacco Smoke Pollution MH - Child, Hospitalized MH - Cross-Sectional Studies MH - *Asthma/diagnosis MH - Allergens MH - Skin Tests PMC - PMC10825742 OTO - NOTNLM OT - aeroallergen sensitization OT - pediatric asthma exacerbation OT - skin prick test EDAT- 2023/01/01 00:00 MHDA- 2024/02/02 06:43 PMCR- 2023/01/01 CRDT- 2024/02/01 04:26 PHST- 2023/09/12 00:00 [received] PHST- 2023/10/17 00:00 [accepted] PHST- 2024/02/02 06:43 [medline] PHST- 2023/01/01 00:00 [pubmed] PHST- 2024/02/01 04:26 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.5455/medarh.2023.77.338-344 [doi] PST - ppublish SO - Med Arch. 2023;77(5):338-344. doi: 10.5455/medarh.2023.77.338-344.